| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |